During the past decade, Vince Lombardi Cancer Clinic - Marinette conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 41 clinical trials were completed, i.e. on average, 273.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 27 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vince Lombardi Cancer Clinic - Marinette" #1 sponsor was "SWOG Cancer Research Network" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "Eastern Cooperative Oncology Group" with 5 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vince Lombardi Cancer Clinic - Marinette" #1 collaborator was "National Cancer Institute (NCI)" with 49 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Vince Lombardi Cancer Clinic - Marinette" are "Breast Cancer" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Colorectal Cancer" (3 trials) and "DS Stage I Plasma Cell Myeloma" (2 trials). Many other conditions were trialed in "Vince Lombardi Cancer Clinic - Marinette" in a lesser frequency.

Most popular intervention types in "Vince Lombardi Cancer Clinic - Marinette" are "Drug" (44 trials), "Other" (24 trials), "Biological" (22 trials), "Radiation" (9 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (16 trials), "Docetaxel" (6 trials), "Gemcitabine" (5 trials), "Quality-of-Life Assessment" (5 trials) and "bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Vince Lombardi Cancer Clinic - Marinette" are 38 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Vince Lombardi Cancer Clinic - Marinette". undefined are not yet recruiting, 1 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Vince Lombardi Cancer Clinic - Marinette, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Vince Lombardi Cancer Clinic - Marinette, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".